maybe release some good news to regain the investors trust or more insiders buying I hope .
Sentiment: Strong Buy
BB could simply be trading around a core position. All funds do that. We simply do not know why they lightened up.
I respect the management and the directors at aTyr Pharma they are all professionals and I believe we will get some very good news soon .
Sentiment: Strong Buy
There could be a million reasons-- that does't mean that they don't like the company. Like perhaps they don't want to own more than 10 days trading volume.
They lowered their position by about 10%. They still own 2.14 million shares and are the #2 holder. The #1 institutional owner in LIFE-- Fidelity-- bought more LIFE in the 1Q and now own 3.55 million shares.
Of the top 10 holders as/of 3/31-- 7 increased their position in the 1Q and 3 decreased their position.
Just saw this afternoon that the Baker Brothers Investments reduced their holding in LIFE during the first quarter of 2016..
For several years, I have followed the BBs as a tag-along partner and find it distressing that they opted to lower their position in LIFE. In my eyes, these guys are excellent assessors of companies, management teams and drugs....so I do not take lightly their reduction.
This stock has been tanking, add in an investigation, and a pipeline in an early phase, and you are still over paying at these prices.
Sentiment: Strong Sell
anything under $4s is a steal .. it is difficult to find undervalued stock in these time . IMO the PPS will no longer be under $4 ... hope we will get some good news soon!
this is risk/reward investment , the company has a technology AND PROMISING PIPELINE and the insiders are taking advantage of the low price so am I , do you own DD .
Paul Schimmel is actually the founder and tRNA Synthetase research is his life's research at the Scripps Research Institute. He has helped found many companies like Regulus, Alnylam, Sirtis, Cubist, Angiosyn and the list goes on but this is his baby now
Since you are too lazy to do your own DD then look no further then the insider buying
and cash per share of $4. The ones that have done their DD are putting their money
where their mouths are while you dribble on this board. Buy or get lost. Thanks
maybe ? but who knows could go much lower. Biotechs can't seem to catch a break this year. It's been pretty ugly in the whole sector.